GB9700855D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB9700855D0
GB9700855D0 GBGB9700855.1A GB9700855A GB9700855D0 GB 9700855 D0 GB9700855 D0 GB 9700855D0 GB 9700855 A GB9700855 A GB 9700855A GB 9700855 D0 GB9700855 D0 GB 9700855D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB9700855.1A
Other versions
GB2321190A (en
GB2321190B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Priority to GB9700855A priority Critical patent/GB2321190B/en
Publication of GB9700855D0 publication Critical patent/GB9700855D0/en
Priority to PCT/GB1998/000105 priority patent/WO1998031355A2/en
Publication of GB2321190A publication Critical patent/GB2321190A/en
Application granted granted Critical
Publication of GB2321190B publication Critical patent/GB2321190B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9700855A 1997-01-16 1997-01-16 Pharmaceutical composition Expired - Fee Related GB2321190B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9700855A GB2321190B (en) 1997-01-16 1997-01-16 Pharmaceutical composition
PCT/GB1998/000105 WO1998031355A2 (en) 1997-01-16 1998-01-14 Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9700855A GB2321190B (en) 1997-01-16 1997-01-16 Pharmaceutical composition

Publications (3)

Publication Number Publication Date
GB9700855D0 true GB9700855D0 (en) 1997-03-05
GB2321190A GB2321190A (en) 1998-07-22
GB2321190B GB2321190B (en) 2000-09-20

Family

ID=10806094

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9700855A Expired - Fee Related GB2321190B (en) 1997-01-16 1997-01-16 Pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB2321190B (en)
WO (1) WO1998031355A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (en) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Pharmaceutical composition
WO2002006523A2 (en) * 2000-07-14 2002-01-24 F. Hoffmann-La Roche Ag Method for detecting pre-disposition to hepatotoxicity
FI20012242A0 (en) * 2001-11-19 2001-11-19 Orion Corp New pharmaceutical compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717643A (en) * 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
AU3140577A (en) * 1976-12-13 1979-06-14 Sterling Drug Inc N-propylnorapormorphine diesters
US4469695A (en) * 1980-02-25 1984-09-04 Ayerst, Mckenna & Harrison, Inc. 2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
US5496836A (en) * 1994-05-05 1996-03-05 Mount Sinai School Of Medicine Of The City University Of New York Use of famotidine and related compounds in the treatment of movement disorders
EP0828513B1 (en) * 1995-05-26 2004-01-21 Pfizer Inc. Combinations for the treatment of parkinsonism containing selective nmda antagonists

Also Published As

Publication number Publication date
GB2321190A (en) 1998-07-22
GB2321190B (en) 2000-09-20
WO1998031355A3 (en) 1998-09-11
WO1998031355A2 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
EP0978288A4 (en) Medicinal composition
GB9818591D0 (en) Pharmaceutical composition
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
HUP0004669A3 (en) Pharmaceutical compositions
IL122920A (en) Castrointestinal drug composition
EP1124557A4 (en) Pharmaceutical composition
HU9700632D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
GB9710632D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition
GB9715614D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060116